Multiple enrichment detection method of low-frequency mutation relevant to non-small cell lung cancer target medicine
A non-small cell lung cancer, low-frequency mutation technology, applied in the detection/testing of microorganisms, biochemical equipment and methods, recombinant DNA technology, etc., can solve the problems of high cost, complex data processing, long detection time, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Example 1. Non-small cell lung cancer targeted drug-related low-frequency mutations 2235_2249del-15, 2236_2250del-15, T790M and L858R multiple enrichment detection method (TaqMan probe method)
[0058] 1. The composition of non-small cell lung cancer targeted drug-related low-frequency mutations 2235_2249del-15, 2236_2250del-15, T790M and L858R multiple enrichment detection kit (TaqMan probe method)
[0059] (1) There are four segments in the target sequence. Including: a section on exon 19 of the human EGFR gene, including the deletion mutation 2235_2249del-15 and 2236_2250del-15 and a total of 85 bp DNA sequence before and after; a section on exon 20 of the human EGFR gene, including the point mutation to be tested T790M and a total of 93bp DNA sequence before and after; a section on exon 21 of the human EGFR gene, including the point mutation L858R to be tested and a total of 109bp DNA sequence before and after; a section on the human β-actin gene, a total of 68bp. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com